Cullgen

San Diego, United States

Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies.

$35.0M raised

May 2023

Series C

Top Investors

HSGHighlight Capital3E BioventuresOctagon Capital AdvisorsMSA Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Cullgen raised?

Cullgen has raised $35.0M in total funding. The most recent round was Series C. The last funding was announced in May 2023.

Who are Cullgen's investors?

Cullgen's investors include HSG, Highlight Capital, 3E Bioventures, Octagon Capital Advisors, MSA Capital.

Where is Cullgen headquartered?

Cullgen is headquartered in San Diego, United States.

What does Cullgen do?

Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies.

What stage is Cullgen at?

Cullgen is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 8, 2023.

MLA

"Cullgen — Funding & Investors." VCBacked, May 8, 2023, https://www.vcbacked.co/company/cullgen. Accessed June 4, 2026.

APA

VCBacked. (2023). Cullgen — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/cullgen

Wikipedia (cite web)

{{cite web |title=Cullgen — Funding & Investors |url=https://www.vcbacked.co/company/cullgen |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 8, 2023.